Download presentation
Presentation is loading. Please wait.
1
Advisor to the Minister of Health
Health reform strategy Debt reduction strategy World Bank workshop Warsaw, 19/05/03 Rudolf Zajac Minister of Health Peter Pažitný Advisor to the Minister of Health
2
Content Fiscal position of Health sector
Where is the beginning of the circle? Stabilisation measures System measures Network measures Debt reduction strategy
3
I. Fiscal position of Health Sector
4
Gap is widening (Cumulative real growth of GDP, 1990=100)
USA EU 15 SR
5
Deficit of Public Finances (% of GDP)
6
Fiscal position of Health sector (% of GDP)
Expenditures Resources Deficit
7
Coverage of the Deficit (% from GDP)
8
… growing debts (in bln. Sk)
Annual change 2002 … 2003 VAT and deregulation … 1,0 Providers: 16,2 … 22,0 Health insurance funds: 13,2 … 15,4
9
Where is the Beginning of the Circle?
10
Challenges and Reactions of the Reform
Growing expectations of the citizens Increasing Costs Limited ability to pay Decreasing of expectations of the citizens Increasing of efficiency Mobilisation of Resources
11
Position of Political Decisions
How much Resources ? Decreasing of high expectations of the citizens Efficiency How wide Treatment Act?
12
Where is the Beginning of the Circle?
Health Care Act Treatment Act New Insurance Act CONSTITUTION Health Insurance Act New Treatment Act Health Care Surveillance Authority Act Chambers Act Health Care Occupations Act Health Care Providers Act
13
Schedule of reform steps
Network measures New system System measures Stabilisation measures 2002 2003 2004
14
III. Stabilisation measures
15
Goals STOP Stopping of debt growth Financial stabilisation of system
16
Stabilisaton measures
Modern definition of the Health Care Introduction of marginal co-payments for Providers New initiatives in Drug Policy
17
… stabilisation of debts (in bln. Sk)
Annual change 2002 … 2003 VAT and deregulation … 1,0 Total savings 2,5 - 3,8 bln. Sk Providers: 16,2 … 19,6 Health insurance funds : 13,2 … 14,2
18
IV. System measures
19
Goals Decreasing of expectations of citizens
Raising the efficiency of the system Mobilisation of Resources (particularly private)
20
System measures NEW Treatment Act NEW Insurance Act
NEW Health Care Surveillance Authority Act
21
1. New Treatment Act A Fully reimbursed B Partially reimbursed C
Not reimbursed Performance Drugs Tools and material
22
Beyond scope of Treatment Act
2. New Insurance Act Voluntary insurance Beyond scope of Treatment Act Compulsory insurance Covering BBP in Treatment Act
23
3. Health Care Surveillance Authority
Strong regulatory body, which monitors: Licences Register of assured Index of risk Solvency of Health Insurance Funds Quality of Health Care Lege artis
24
Goal: Active role purchaser
Purchasing of goods Drug policy Influencing the price Purchasing of services Provider
25
V. Network measures
26
Current conditions – there is no feedback in the system
Hospitals and LZZ SKK Health Insurance Fund Patient Primary care Secondary care SKK
27
Goals Increasing allocative and technical efficiency
Increasing Quality Enhancement of effective access Reinforcement of competition Equality of chances
28
Network measures NEW Chambers Act
NEW Health Care Providers and Institutions Act NEW Health Care Occupations Act
29
Goal: Management of the patient in the future - interaction
Hospitals and LZZ Patient Purchaser Primary and secondary care
30
VI. Debt reduction strategy
31
Structure of the external debt (SKK billion)
Pharmacies (7,0) HIF Without Perspektiva (2,2) Without Redistrib. Fund (3,8) Contributors Unpaid insurance (11,0) Fines, Penalties (8,5) Public finances (2,2) Primary and secondary care (1,3) Drugs (4,5) Inpatient facilities Public finances (4,1) Energy (2,9) Others (4,6)
32
Receivables after maturity
Maturity dates Annual expenditures SKK billion Receivables after maturity Maturity dates in days Public pharmacies 20,2 7,0 Hospital pharmacies 5,1 4,5 Energy suppliers 1,3 2,9
33
Bailing out the system Subject of bailing out:
Pharmacies (7,0) Subject of bailing out: Stock of external debt to Public finances (2,2) Primary and secondary care (1,3) Drugs (4,5) Public finances (4,1) Energy (2,9) Others (4,6)
34
How much is that? (SKK billion)
Annual health budget in 2002: SKK 68 billion GDP in 2002: SKK 1062 billion Pharmacies (7,0) Public finances (2,2) Primary and secondary care (1,3) 26,6 Drugs (4,5) Public finances (4,1) 40,0% 2,5% Energy (2,9) Others (4,6)
35
Special agency MOF, MOH, NPF
receivables HIF Pharmacies (7,0) Special agency “Creditor” Purchase of receivables from creditors Public finances (2,2) Primary and secondary care (1,3) receivables Inpatient facilities Drugs (4,5) Public finances (4,1) Energy (2,9) Others (4,6) cash
36
Resources receivables cash Pharmacies (7,0) Special agency “Creditor”
Purchase of payables from creditors National Property Fund Public finances (2,2) Primary and secondary care (1,3) Drugs (4,5) Ministry of finance Issue of bonds Public finances (4,1) Energy (2,9) Others (4,6) cash
37
Schedule of debt reduction 1. Phase
Pharmacies (7,0) HIF Without Perspektiva (2,2) Without Redistrib. Fund (3,8) Contributors Unpaid insurance (11,0) Fines, Penalties (8,5) Public finances (2,2) Primary and secondary care (1,3) Drugs Inpatient facilities (decentralized) (6) Public finances Energy Others
38
Schedule of debt reduction 2. Phase
Pharmacies (7,0) HIF Without Perspektiva (2,2) Without Redistrib. Fund (3,8) Contributors Unpaid insurance (11,0) Fines, Penalties (8,5) Public finances (2,2) Primary and secondary care (1,3) Drugs (4,5) Inpatient facilities (decentralized) Public finances (4,1) Energy (2,9) Others (4,6)
39
Schedule of debt reduction 3. Phase
Pharmacies (7,0) HIF Without Perspektiva (2,2) Without Redistrib. Fund (3,8) Contributors Unpaid insurance (11,0) Fines, Penalties (8,5) Public finances (2,2) Primary and secondary care (1,3) Drugs Inpatient facilities (state owned) (10) Public finances Energy Others
40
... ??? ... We are lucky, the hole is not on our side
41
Thank You for Your Attention
We are looking forward to Your comments and for further information attend
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.